Application Notes

AAV Production – How To Improve Transfection Efficiency and Titer Yield

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

Expansion of Adherent HEK293T Cells in Flasks in Chemically Defined Cell Culture Media

Lentrivirus Production Protocol in Serum-Free Conditions – How To Improve Transfection Efficiency and Titer Yield

OptiVERO – Formulation of a blood-free and chemically defined virus production media for VERO cells

OptiVERO – Virus Production Using VERO Cells in Flasks without Serum in Chemically Defined Cell Culture Media Application Note

OptiVERO – Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media

Blog

Improvement of Vaccine Manufacturing Process with Use of Recombinant HSA Excipient

InVitria Expands European and UK Footprint

SARS-CoV2 and Influenza – Double Threat

Solving the Vaccine Supply Challenge

The Emergence of Serum-Free Cell Culture Media – Blood-Free Chemically Defined Components

Interviews

Blood-Free Fetal Bovine Serum Alternatives in Cell Culture Media

Journal Articles (DOI Links)

Formulation and production of a blood-free and chemically defined virus production media for VERO cells

Improvements in Viral Vector Manufacturing Process with Chemical Definition of Cell Culture Media & Excipients

Posters

Chemically Defined iCELLis® Bioreactor-Based Lentiviral Vector Mass Production

Chemically Defined iCELLis® Bioreactor-Based Viral Vector Manufacturing – Application of Aber Biomass Probes to Inform Transfection Timing

Improving Vaccine Development, Performance, and Stability with Recombinant HSA Excipient

Product Brochures

Product Catalog

ITSE AF – Brochure

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

SDS

Exbumin – Safety Data Sheet

ITSE AF – Safety Data Sheet

Use Guidelines

Exbumin – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

OptiVERO – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Cellastim S – Recombinant Human Serum Albumin in the Generation of Functional Cardiomyocytes from Pluripotent Stem Cells

Emergence of Blood-Free Recombinant Human Albumin

Formulation and production of a blood‐free and chemically defined virus production media for VERO cells

Optimizing the Performance of LNP and Liposome Therapeutics with Blood-Free Recombinant Albumin